hVIVO plc (AIM:HVO)
London · Delayed Price · Currency is GBP · Price in GBX 6.58
+0.06 (0.92%)
Oct 31, 2025, 4:35 PM GMT+1
hVIVO Market Cap
hVIVO has a market cap or net worth of 44.77 million as of October 31, 2025. Its market cap has decreased by -76.71% in one year.
Market Cap
44.77M
Enterprise Value
36.18M
Revenue
54.47M
Ranking
n/a
PE Ratio
8.56
Stock Price
6.58
Market Cap Chart
Since July 1, 2019, hVIVO's market cap has increased from 17.24M to 44.77M, an increase of 159.71%. That is a compound annual growth rate of 16.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 31, 2025 | 44.77M | -67.90% |
| Dec 31, 2024 | 139.48M | -13.68% |
| Dec 29, 2023 | 161.59M | 140.84% |
| Dec 30, 2022 | 67.09M | -56.52% |
| Dec 31, 2021 | 154.31M | -10.47% |
| Dec 31, 2020 | 172.36M | 1,388.01% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jul 1, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 194.55B |
| GSK plc | 71.65B |
| Haleon | 31.24B |
| Smith & Nephew | 11.59B |
| ConvaTec Group | 4.84B |
| Hikma Pharmaceuticals | 4.04B |
| HUTCHMED (China) | 1.88B |
| Genus | 1.68B |